Risk factors for predicting extended-spectrum β-lactamase-producing Enterobacterales (ESBLE) infections in non-urinary isolates.

Autor: Burgoon R; Department of Pharmacy, Medical University of South Carolina (MUSC) Health, Charleston, SC, USA., Hamby A; Department of Pharmacy, Medical University of South Carolina (MUSC) Health, Charleston, SC, USA., Weeda E; Department of Clinical Pharmacy & Outcome Sciences, Medical University of South Carolina, Charleston, SC, USA., Raux BR; bioMerieux, Inc., Salt Lake City, UT, USA., Hornback KM; Department of Pharmacy, Medical University of South Carolina (MUSC) Health, Charleston, SC, USA.

Publikováno v: Antimicrobial stewardship & healthcare epidemiology : ASHE [Antimicrob Steward Healthc Epidemiol] 2023 Jul 11; Vol. 3 (1), pp. e123. Date of Electronic Publication: 2023 Jul 11 (Print Publication: 2023).

Evaluation of the impact of nasal colonization with methicillin-resistant Staphylococcus aureus on left ventricular assist device infections.

Autor: Koscal LJ; Department of Pharmacy, University of Florida Health at Jacksonville, Jacksonville, Florida., Meadows H; Department of Pharmacy, Medical University of South Carolina, Charleston, South Carolina., Raux BR; Department of Pharmacy, Medical University of South Carolina, Charleston, South Carolina., Mediwala KN; Department of Pharmacy, Medical University of South Carolina, Charleston, South Carolina., Weeda E; Medical University of South Carolina, College of Pharmacy, Charleston, South Carolina., Houston B; Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina., Jandhyala D; Division of Infectious Diseases, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina., Hawn JM; Department of Pharmacy, Medical University of South Carolina, Charleston, South Carolina.

Publikováno v: Antimicrobial stewardship & healthcare epidemiology : ASHE [Antimicrob Steward Healthc Epidemiol] 2022 May 10; Vol. 2 (1), pp. e79. Date of Electronic Publication: 2022 May 10 (Print Publication: 2022).

Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections.

Autor: Rebold N; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA., Morrisette T; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.; Department of Pharmacy Services, Medical University of South Carolina, Charleston, South Carolina, USA.; Department of Pharmacy & Outcomes Sciences, Medical University of South Carolina College of Pharmacy, Charleston, South Carolina, USA., Lagnf AM; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA., Alosaimy S; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA., Holger D; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA., Barber K; Department of Pharmacy, University of Mississippi Medical Center, Jackson, Mississippi, USA.; Department of Pharmacy Practice, University of Mississippi School of Pharmacy, Jackson, Mississippi, USA., Justo JA; Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia, South Carolina, USA.; Department of Pharmacy, Prisma Health-Midlands, Columbia, South Carolina, USA., Antosz K; Department of Pharmacy, Prisma Health-Midlands, Columbia, South Carolina, USA., Carlson TJ; Department of Clinical Sciences, Fred Wilson School of Pharmacy, High Point University, High Point, North Carolina, USA., Frens JJ; Department of Pharmacy, Moses H. Cone Memorial Hospital, Cone Health, Greensboro, North Carolina, USA., Biagi M; College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA.; Department of Pharmacy, Swedish American Health System, Rockford, Illinois, USA., Kufel WD; Department of Pharmacy Practice, Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton, New York, USA.; Department of Medicine, State University of New York Upstate Medical University, Syracuse, New York, USA., Moore WJ; Department of Pharmacy, Northwestern Memorial Hospital, Chicago, Illinois, USA., Mercuro N; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.; Department of Pharmacy, Maine Medical Center, Portland, Maine, USA., Raux BR; Department of Pharmacy Services, Medical University of South Carolina, Charleston, South Carolina, USA., Rybak MJ; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.; Department of Pharmacy Services, Detroit Medical Center, Detroit, Michigan, USA.; Division of Infectious Diseases, Department of Medicine, School of Medicine, Wayne State University, Detroit, Michigan, USA.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2021 Dec 09; Vol. 8 (12), pp. ofab554. Date of Electronic Publication: 2021 Dec 09 (Print Publication: 2021).

Assessment of Fosfomycin for Complicated or Multidrug-Resistant Urinary Tract Infections: Patient Characteristics and Outcomes.

Autor: Giancola SE; Department of Pharmacy and Health Systems Sciences, Northeastern University, Boston, Mass., USA., Mahoney MV, Hogan MD, Raux BR, McCoy C, Hirsch EB

Publikováno v: Chemotherapy [Chemotherapy] 2017; Vol. 62 (2), pp. 100-104. Date of Electronic Publication: 2016 Oct 28.

Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates.

Autor: Hirsch EB; Northeastern University, Boston, MA, USA; Beth Israel Deaconess Medical Center, Boston, MA, USA. Electronic address: e.hirsch@neu.edu., Raux BR; Northeastern University, Boston, MA, USA., Zucchi PC; Northeastern University, Boston, MA, USA., Kim Y; Northeastern University, Boston, MA, USA., McCoy C; Beth Israel Deaconess Medical Center, Boston, MA, USA., Kirby JE; Beth Israel Deaconess Medical Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Wright SB; Beth Israel Deaconess Medical Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Eliopoulos GM; Beth Israel Deaconess Medical Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

Publikováno v: International journal of antimicrobial agents [Int J Antimicrob Agents] 2015 Dec; Vol. 46 (6), pp. 642-7. Date of Electronic Publication: 2015 Sep 30.